Plus Therapeutics Introduces Reyobiq as FDA-Accepted Name
20 Mar 2025 //
GLOBENEWSWIRE
Plus Publishes Ph1 Rhenium-186 Data In Glioblastoma In Nature
07 Mar 2025 //
GLOBENEWSWIRE
Plus Therapeutics Gets FDA Orphan Drug Nod For Rhenium-186 In Lung Mets
06 Mar 2025 //
GLOBENEWSWIRE
Plus Therapeutics to Present Data from ReSPECT-GBM Clinical Trial
23 Aug 2022 //
GLOBENEWSWIRE
Plus Therapeutics Reports Commercial Manufacturing Supply Deal for Its Lead Drug
01 Sep 2021 //
BIO SPACE